14May
Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By:
Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/
Related
Seyfarth Synopsis: Earlier this year, in New Prime, the Supreme Court decisively held that the Feder...
Read More >
Perhaps the most shocking aspect of employment-related cases from the 2018-2019 Supreme Court term t...
Read More >
Seyfarth Synopsis: In our fourth installment on the presidential candidates’ stances on future of w...
Read More >
On October 24, 2019, Senator Mike Lee (R-UT) introduced the Protecting American Jobs Act. The bill,...
Read More >
INTRODUCTION - COVID-19 and the ensuing economic turmoil are continuing to adversely impact business...
Read More >
Pacta sunt servanda, i.e., agreements must be kept. This applies in both good economies and bad. Co...
Read More >